ArrowMark Colorado Holdings LLC Sells 631,510 Shares of Mirion Technologies, Inc. (NYSE:MIR)

ArrowMark Colorado Holdings LLC lessened its stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 21.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,368,550 shares of the company's stock after selling 631,510 shares during the quarter. ArrowMark Colorado Holdings LLC owned 1.02% of Mirion Technologies worth $41,331,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. US Bancorp DE lifted its holdings in Mirion Technologies by 3,248.7% during the 4th quarter. US Bancorp DE now owns 6,262 shares of the company's stock worth $109,000 after buying an additional 6,075 shares during the last quarter. Tower Research Capital LLC TRC grew its position in Mirion Technologies by 162.9% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock valued at $116,000 after buying an additional 4,120 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in shares of Mirion Technologies in the 4th quarter valued at approximately $120,000. KBC Group NV raised its position in Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after acquiring an additional 2,254 shares in the last quarter. Finally, Corient Private Wealth LLC acquired a new position in Mirion Technologies during the fourth quarter worth about $187,000. Hedge funds and other institutional investors own 78.51% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Citigroup lowered their price target on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Robert W. Baird cut their price objective on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, April 4th. Finally, B. Riley cut their price objective on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $18.75.

Mirion Technologies Stock Up 1.4 %

Shares of MIR stock traded up $0.22 on Thursday, hitting $16.32. The company's stock had a trading volume of 216,658 shares, compared to its average volume of 1,676,747. The firm's fifty day moving average price is $14.56 and its 200-day moving average price is $15.70. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of -85.89 and a beta of 0.74.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. The business had revenue of $202.00 million for the quarter, compared to analyst estimates of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. Mirion Technologies's revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.06 earnings per share. Research analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.